Penile squamous cell carcinoma (PSCC) is a rare cancer with orphan disease designation
and a prevalence of 0.1–1 per 100,000 men in high-income countries, but it constitutes up to …

Penile cancer is a rare genitourinary malignancy that is associated with poor outcomes and
severely limited therapeutic options that are generally non-curative when used to treat …

Background The incidence of penile cancer in Europe lies in the range of 0.9 to 2.1 cases
per 100 000 persons per year. Carcinogenesis is associated with human papilloma virus …

Penile cancer is a rare malignancy, particularly in industrialized nations. In the United
States, rates are approximately less than 1 per 100,000 men per year with just over 2000 …

Context Lymph node (LN) involvement in penile cancer is associated with poor survival.
Early diagnosis and management significantly impact survival, with multimodal treatment …

Purpose: Management of squamous cell carcinoma of the penis changed in recent decades
in favor of penile sparing surgery. We assessed whether penile sparing therapies were …

Background We provide updated estimates of survival and survival trends of male genital
tumours (prostate, testicular and penis cancers), in Europe and across European areas …

Penile cancer is a rare disease that causes considerable physical and psychological patient
morbidity, especially at advanced stages. Patients with low-stage nodal metastasis can …

Purpose: The incidence of penile cancer is increasing, and is suggested to be explained by
changes in sexual practice and increased exposure of men to sexually transmitted high risk …

Background Sentinel node (SN) biopsy in penile cancer is typically performed using a
combination of radiocolloid and blue dye. Recently, the hybrid radioactive and fluorescent …